TWD
JAZZ icon

True Wealth Design’s Jazz Pharmaceuticals JAZZ Stock Holding History

True Wealth Design’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$77.1K Buy
320
+120
+60% +$26.3K 0.02% 336
2026
Q1 		$37.8K Buy
200
+130
+186% +$22.7K 0.01% 480
2025
Q4 		$11.9K Buy
70
+54
+338% +$8.28K ﹤0.01% 797
2025
Q3 		$2.11K Hold
16
– – ﹤0.01% 1438
2025
Q2 		$1.7K Buy
16
+8
+100% +$869 ﹤0.01% 1247
2025
Q1 		$994 Buy
8
+1
+14% +$130 ﹤0.01% 1269
2024
Q4 		$863 Buy
+7
New +$825 ﹤0.01% 974
2023
Q4 		– Sell
-5,627
Closed -$728K – 800
2023
Q3 		$728K Buy
5,627
+344
+7% +$45.8K 0.24% 79
2023
Q2 		$655K Buy
5,283
+131
+3% +$17.6K 0.24% 96
2023
Q1 		$754K Buy
5,152
+139
+3% +$20.6K 0.32% 80
2022
Q4 		$799K Buy
+5,013
New +$735K 0.37% 48

Other funds holding JAZZ

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

True Wealth Design's JAZZ Position: Q2 2026 in Review

True Wealth Design increased its Jazz Pharmaceuticals (JAZZ) stake by 60% in Q2 2026, buying an estimated $26.3K and bringing the position to 320 shares worth $77.1K. The position accounts for 0.02% of the portfolio, ranked #336.

True Wealth Design first reported a position in JAZZ in Q4 2022 and has held it in 11 quarters since. The position peaked at $799K in Q4 2022. 87 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • True Wealth Design held 320 shares of Jazz Pharmaceuticals worth $77.1K as of Q2 2026.
  • True Wealth Design bought 120 Jazz Pharmaceuticals shares in Q2 2026, an estimated $26.3K.
  • Jazz Pharmaceuticals made up 0.02% of True Wealth Design's portfolio in Q2 2026, its #336 holding.
  • True Wealth Design first reported a position in Jazz Pharmaceuticals in Q4 2022 and has held it in 11 quarters since.
  • True Wealth Design's Jazz Pharmaceuticals position peaked at $799K in Q4 2022.
  • 87 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.